杂合型PU.1突变与急性髓系白血病相关。 - Suppr

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

作者信息

Mueller Beatrice U, Pabst Thomas, Osato Motomi, Asou Norio, Johansen Lisa M, Minden Mark D, Behre Gerhard, Hiddemann Wolfgang, Ito Yoshiaki, Tenen Daniel G

出版信息

Blood. 2003 Mar 1;101(5):2074. doi: 10.1182/blood-2002-12-3903.

DOI:10.1182/blood-2002-12-3903

PMID:12584148

Abstract

摘要

相似文献

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

Blood. 2003 Mar 1;101(5):2074. doi: 10.1182/blood-2002-12-3903.

Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?

Blood. 2002 Dec 15;100(13):4680-1. doi: 10.1182/blood-2002-08-2563.

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

Blood. 2002 Aug 1;100(3):998-1007. doi: 10.1182/blood.v100.3.998.

Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia: a study of the AML Study Group Ulm (AMLSG ULM).

Blood. 2003 Nov 15;102(10):3850; author reply 3850-1. doi: 10.1182/blood-2003-08-2654.

FLT3 mutations are associated with other molecular lesions in AML.

Leuk Res. 2004 Jan;28(1):19-23. doi: 10.1016/s0145-2126(03)00125-5.

PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain.

Blood. 2004 Dec 1;104(12):3437-44. doi: 10.1182/blood-2004-06-2234. Epub 2004 Aug 10.

FLT3 mutations in myeloid sarcoma.

Br J Haematol. 2004 Sep;126(6):785-91. doi: 10.1111/j.1365-2141.2004.05124.x.

Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.

Blood. 2003 Apr 15;101(8):3164-73. doi: 10.1182/blood-2002-06-1677. Epub 2002 Dec 5.

Loss of PU.1: one of the many roads to myeloid leukemia.

Cell Cycle. 2006 Apr;5(7):673-4. doi: 10.4161/cc.5.7.2619. Epub 2006 Apr 1.

Flt3 mutations and leukaemia.

Br J Haematol. 2003 Aug;122(4):523-38. doi: 10.1046/j.1365-2141.2003.04500.x.

引用本文的文献

Construction of gastric cancer prognostic signature based on the E26 transcription factor and the identification of novel oncogene ELK3.

Am J Cancer Res. 2024 Apr 15;14(4):1831-1849. doi: 10.62347/RVBP7871. eCollection 2024.

Partitioned usage of chromatin remodelers by nucleosome-displacing factors.

Cell Rep. 2022 Aug 23;40(8):111250. doi: 10.1016/j.celrep.2022.111250.

Janus Kinase Mutations in Mice Lacking PU.1 and Spi-B Drive B Cell Leukemia through Reactive Oxygen Species-Induced DNA Damage.

Mol Cell Biol. 2020 Aug 28;40(18). doi: 10.1128/MCB.00189-20.

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.

Cell Death Dis. 2016 Oct 27;7(10):e2442. doi: 10.1038/cddis.2016.346.

Characteristics of Antisense Transcript Promoters and the Regulation of Their Activity.

Int J Mol Sci. 2015 Dec 23;17(1):9. doi: 10.3390/ijms17010009.

Genome-scale definition of the transcriptional programme associated with compromised PU.1 activity in acute myeloid leukaemia.

Leukemia. 2016 Jan;30(1):14-23. doi: 10.1038/leu.2015.172. Epub 2015 Jul 1.

Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.

Leukemia. 2014 Apr;28(4):749-60. doi: 10.1038/leu.2013.202. Epub 2013 Jul 4.

Polycomb group proteins: navigators of lineage pathways led astray in cancer.

Nat Rev Cancer. 2009 Nov;9(11):773-84. doi: 10.1038/nrc2736.

Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.

Int J Hematol. 2005 Jun;81(5):368-77. doi: 10.1532/ijh97.05051.

Gefitinib induces myeloid differentiation of acute myeloid leukemia.

Blood. 2005 Oct 15;106(8):2841-8. doi: 10.1182/blood-2005-02-0488. Epub 2005 Jul 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献